As of 2026-06-21, the Relative Valuation of Atossa Therapeutics Inc (ATOS) is (32.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.01 USD, the upside of Atossa Therapeutics Inc based on Relative Valuation is -1715.7%.
The range of the Relative Valuation is (14.96) - (38.06) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.2x - 15.8x | 14.5x |
| Forward P/E multiples | 5.4x - 16.1x | 12.5x |
| Fair Price | (14.96) - (38.06) | (32.48) |
| Upside | -844.4% - -1993.3% | -1715.7% |
| Date | P/E |
| 2026-06-12 | -1.02 |
| 2026-06-11 | -1.07 |
| 2026-06-10 | -1.83 |
| 2026-06-09 | -1.83 |
| 2026-06-08 | -1.89 |
| 2026-06-05 | -1.86 |
| 2026-06-04 | -2.02 |
| 2026-06-03 | -1.95 |
| 2026-06-02 | -2.02 |
| 2026-06-01 | -2.12 |
| 2026-05-29 | -2.17 |
| 2026-05-28 | -2.16 |
| 2026-05-27 | -2.13 |
| 2026-05-26 | -2.06 |
| 2026-05-22 | -2.06 |
| 2026-05-21 | -2.07 |
| 2026-05-20 | -2.01 |
| 2026-05-19 | -1.97 |
| 2026-05-18 | -1.99 |
| 2026-05-15 | -2.02 |
| 2026-05-14 | -2.14 |
| 2026-05-13 | -2.15 |
| 2026-05-12 | -2.15 |
| 2026-05-11 | -2.29 |
| 2026-05-08 | -2.33 |
| 2026-05-07 | -2.36 |
| 2026-05-06 | -2.41 |
| 2026-05-05 | -2.32 |
| 2026-05-04 | -2.44 |
| 2026-05-01 | -2.22 |
| 2026-04-30 | -2.23 |
| 2026-04-29 | -2.19 |
| 2026-04-28 | -2.28 |
| 2026-04-27 | -2.27 |
| 2026-04-24 | -2.37 |
| 2026-04-23 | -2.38 |
| 2026-04-22 | -2.47 |
| 2026-04-21 | -2.40 |
| 2026-04-20 | -2.56 |
| 2026-04-17 | -2.42 |
| 2026-04-16 | -2.40 |
| 2026-04-15 | -2.39 |
| 2026-04-14 | -2.22 |
| 2026-04-13 | -2.21 |
| 2026-04-10 | -2.05 |
| 2026-04-09 | -2.07 |
| 2026-04-08 | -2.00 |
| 2026-04-07 | -2.03 |
| 2026-04-06 | -2.14 |
| 2026-04-02 | -2.23 |